Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera
Clinical trial NCT06033586 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06033586
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2026-04-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.